“Belantamab Mafodotin Gives Patients a Chance,” Says Diane Moran – International Myeloma Foundation

International Myeloma Foundation (IMF) shared a post on X:

” ‘Belantamab mafodotin gives patients a chance – not a guarantee, but a chance – to reclaim moments that matter,’ says IMF Interim CEO/SVP of Strategic Planning Diane Moran at today’s FDA ODAC meeting on belantamab mafodotin for myeloma.

Watch live.”